Closed out final piece for +170%... Most gap downs should not be bought, but in this case the selling was overdone due to liquidation of the position by investors focused on no longer receiving dividends instead of the long-term value of the business. The stock quickly rebounded as a new shareholder base of value investors stepped into the stock.

04-Nov-16 12:00 ET SCALP ScalpTrader Watchlist (3.15 -5.25) Just wanted to point out that I'm in the market buying some of this MDCA (3.15 -5.25, -62%) for a swing trade. This is a roll-up advertising agency that has had disappointing results for at least a couple qtrs in a row. Stock is down from $24 since March and from $18.50 since late-July. They suspended the dividend today, which I think is the reason for the massive drop. Also the fall below $5 may be causing an additional group of institutional holders to run for the exits. This might have been seen as appropriate for a more conservative mutual fund portfolio before the dividend suspension and plunge below $5.00 This isn't going into any of my official portfolios, just wanted to let you know what I'm doing with it. I don't feel like I know the name well enough at this point to place it into one of the official portfolios. Even with the lowered guidance, analysts' reduced price tgts are still well above the current price ($7-8 range) and at least a couple firms are suggesting that co has become a takeover target at these valuations. 04-Nov-16 15:57 ET SCALP ScalpTrader: MDCA follow-up (3.40 -5.00) I wanted to follow up that after listening to MDCA conf call, I decided to add another 1/3 to the position. I think much of this selling is due to dividend focused investors bailing b/c co eliminated the dividend. Was a smart move by the new mgmt team, as a co like this never should have offered such a rich dividend. Co appears to have kitchen-sinked this qtr so that they can start 2017 with great momentum. I think this will attract value buyers who think MDCA gets acquired. 09-Nov-16 13:33 ET SCALP ScalpTrader: MDCA -- Nice pop on news that SEC investigation has been settled. Stock hit a high of $4.15. I'm holding onto my shares for higher prices over time. Currently in the money about 20% on the position. (3.80 +0.25) 15-Nov-16 09:54 ET SCALP ScalpTrader: MDCA Update -- Locking in profits on 2/3 for +62%. (5.10 +0.05) For those trading MDCA with me, wanted to point out that I'm starting to lock in some profits following the 62% run in our favor. Holding onto approx. 1/3 of the position, as a longer-term play. I'll be looking for a pullback in price to rebuild the position. Link to original entry. 18-Nov-16 10:48 ET SCALP ScalpTrader: MDCA Update -- I'm trimming 75% of remaining MDCA position for +110% in just two weeks. (6.60 +0.20) I'm going to keep a small piece on just b/c I think there is long-term upside. However, I'm hoping for a pullback in the stock in order to reload. 15-Feb-17 09:31 ET SCALP ScalpTrader: MDCA Update -- Locking in profits on remaining position for +170%, as stock gaps up on news of Goldman Sachs investment (8.50 +1.75) • Originally purchased this position in Nov as it gapped down on earnings. • Today, I'm using the 26% gap higher on the Goldman Sachs investment news to take profits on the remainder of the position.